Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1698134 | 1.00 | CTBP2 (0.39) | CTBP2POLBTAS1R3TAS1R1MAOB | |
| SCHEMBL12032110 | 1.00 | CTBP2 (0.39) | CTBP2POLBTAS1R3TAS1R1MAOB | |
| SCHEMBL2437285 | 0.81 | HPGD (0.41) | MEN1HPGDKMT2A | |
| SCHEMBL3363732 | 0.81 | HPGD (0.41) | MEN1HPGDKMT2A | |
| SCHEMBL13307837 | 0.81 | HPGD (0.41) | MEN1HPGDKMT2A | |
| SCHEMBL21859555 | 0.81 | TAAR1 (0.47) | CTBP2POLBMAOBTAAR1MEN1 | |
| SCHEMBL692554 | 0.78 | CTBP2 (0.49) | CTBP2POLBMAOBTAAR1MEN1 | |
| SCHEMBL9528448 | 0.78 | MAOB (0.45) | CTBP2POLBMAOBTAAR1MEN1 | |
| SCHEMBL19047449 | 0.76 | POLB (0.43) | CTBP2POLBMAOBTAAR1MEN1 | |
| SCHEMBL19006263 | 0.76 | MMP8 (0.48) | CTBP2POLBMAOBMEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3085759-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-2585569-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-08-24 | — | — | EP | disclosed |
| US-8609603-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | CTBP2 4511/4885POLB 1134/4885TAS1R3 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.